Fortis board gives nod for diagnostic arm IPO, net profit drops 9% in Q1 FY24

Fortis board gives nod for diagnostic arm IPO, net profit drops 9% in Q1 FY24
The Economic Times
Published onThe Economic Times
Publish Date4 August 2023
Reading time1 Min

Share on Social Links

Category

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore

Fortis Healthcare board on Friday approved its diagnostic arm Agilus to initiate an initial public offer process, by way of an offer for sale by the latter's existing and eligible shareholders in the IPO. Agilus was earlier called SRL Diagnostics, which was rebranded in May this year.

Tags

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore

Stay Connected, Stay Informed –

Join Our

WhatsApp

Channel!

Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.

Pre Ipo

Pre Ipo

Upcoming IPO

Upcoming IPO

Unicorn

Unicorn